Schechter Investment Advisors’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Schechter Investment Advisors’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134,747	Closed	-$1.36M	–	889
2022 Q4	$1.36M	Sell	134,747 -10,810	-7%	-$108K	0.12%	206
2022 Q3	$1.44M	Sell	145,557 -6,040	-4%	-$59.5K	0.14%	175
2022 Q2	$1.48M	Buy	151,597 +53,685	+55%	+$526K	0.14%	160
2022 Q1	$958K	Buy	97,912 +1,860	+2%	+$18.1K	0.09%	322
2021 Q4	$931K	Buy	+96,052	New	+$934K	0.08%	329

Schechter Investment Advisors's MSAC Position: Q1 2023 in Review

Schechter Investment Advisors sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 134,747 shares — an estimated $1.36M sold.

Schechter Investment Advisors first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $1.48M in Q2 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Schechter Investment Advisors reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Schechter Investment Advisors sold 134,747 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $1.36M.
Schechter Investment Advisors first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Schechter Investment Advisors's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1.48M in Q2 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Schechter Investment Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.